Podcasts Highlight Patients as Partners 2019
A new podcast series highlights panel discussions during Patients as Partners US 2019. The podcasts include: Engaging with Communities to [...]
Podcast Focuses on Price Transparency Models
A Patients Rising podcast spotlights how price transparency models could help empower patients. "Unfortunately, patients usually don’t know the cost [...]
Article Highlights MEAs, Implementation Challenges
A recent article published in Value in Health looks at the current landscape of managed entry agreements, as well as [...]
ISPOR Report Looks at Missing Data in HEOR
The ISPOR Statistical Methods in HEOR Special Interest Group in a new report considers how to account for missing data [...]
A Look at Cummings’ Drug Pricing Law
While the Elijah Cummings Lower Drug Costs Now Act would reduce drug prices, The Commonwealth Fund says the impact on [...]
Thompson: ISPOR in the Time of Corona
Value & Outcomes Spotlight Editor-in-Chief David Thompson in the March/April issue says the COVID-19 outbreak has turned the world upside [...]
Novo Nordisk Lowers Costs of Insulin Amid Pandemic
Novo Nordisk is extending a hand to diabetes patients amid the COVID-19 pandemic, according to a STAT report. According to [...]
Inadvertent Release of Remdesivir Study Reveals Lackluster Results
An accidental release of study results of a clinical trial in China revealed Gilead's remdesivir failed to prevent patients from [...]
The Future of Value-Based Contracting
Joshua Cohen in a recent article published in Value in Health highlights the rising interest in value-based contracts. Cohen notes [...]
Preparing for a COVID-19 Vaccine
A recent Health Affairs blog post considers the challenges that lie ahead of a potential COVID-19 vaccine. The rollout of [...]
Column Considers Drug Pricing in U.S., COVID-19 Vaccine
A recent column published in the Los Angeles Times looks at how the U.S. handles drug pricing, and what that [...]
Report: Pharma Sees Reputation Bump Among Patient Groups
A recent survey suggests the pharmaceutical industry has seen a slight bump in reputation among patient organizations, STAT reports. The [...]
Report: Jaguar Health Triples Price of Drug After Seeking Expanded Use
Jaguar Health this month tripled the price of Mytesi after asking the FDA to expand its use to coronavirus patients, [...]
Aetion, HealthVerity Launch New Tools for Assessing COVID-19 Treatments
Aetion and HealthVerity have launched a new set of tools for biopharma companies and regulators looking to assess new COVID-19 [...]
IQVIA Execs Share Insight into COVID-19 Impact
IQVIA executives in an on-demand webinar highlight the impact of the COVID-19 pandemic on the life sciences industry. The briefing [...]
AMCP’s Andel Talks Drug Pricing Proposals Ahead of Election
Melissa Andel, Applied Policy vice president of health policy, discussed during an AMCP eLearning Days presentation drug pricing proposals in [...]
COVID-19 Evidence Accelerator Aims to Facilitate Collaboration
The Reagan-Udall Foundation, in partnership with Friends of Cancer Research, recently launched a new initiative for the FDA aimed at [...]
Tufts-CEVR Announces First Senior Fellow
Tufts Medical Center's Center for the Evaluation of Value and Risk in Health (CEVR) announced Sean Tunis would join the [...]
Collaboration Announces Framework to Bolster COVID-19 Research
A new multi-company collaborative announced the launch of a new framework aimed at bolstering research and development of COVID-19 treatments. [...]
ICER Taps Campbell as Senior VP for Health Economics
The Institute for Clinical and Economic Review (ICER) on Thursday, April 23, announced the appointment of Jonathan Campbell as the [...]
Retail Medicine Spending Expected to Remain Stable
New projections from the Centers for Medicare & Medicaid Services (CMS) suggest retail medicine spending will remain stable through the [...]
Supreme Court Delays Arguments on Arkansas’s PBM Law
The Supreme Court has pushed back arguments in a case involving an Arkansas law that regulates the rates at which [...]
Startups Push Forward Despite Pandemic
The COVID-19 pandemic isn't stopping some startups from pushing forward, according to a MedCity News report. According to the report, [...]
JCPH’s Nash Discusses Return to Normalcy After First Wave of COVID-19
Jefferson College of Public Health Founding Dean Emeritus David Nash says testing will be key as the U.S. looks to [...]
PhRMA: Value-Based Contracts Lead to Solid Out-of-Pocket Savings
Value-based arrangements between pharma and Express Scripts generated about $800,000 in savings on patients' out-of-pocket costs, PhRMA suggests in a [...]